American Academy of Dermatology evidence-based guideline development process: Responding to new challenges and establishing transparency

Journal of the American Academy of Dermatology

Volumn 64, Issue 6, 2011, Pages

  Smith Begolka, Wendy ^a   Elston, Dirk M ^b   Beutner, Karl R ^c,d  

^a AMERICAN ACADEMY OF DERMATOLOGY   (United States)

^b GEISINGER MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Solano Dermatology Associates   (United States)

Author keywords

clinical guidelines; conflict of interest; evidence based guidelines; methodology; transparency

Indexed keywords

AMERICAN ACADEMY OF DERMATOLOGY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONFLICT OF INTEREST; DERMATOLOGY; EVIDENCE BASED GUIDELINE; EVIDENCE BASED PRACTICE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL SPECIALIST; MEDICINE; PATIENT ADVOCACY; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; PUBLIC HEALTH; REIMBURSEMENT; REVIEW; SOCIETY;

EID: 79956087985     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.10.029     Document Type: Editorial

References (46)

1. Field M, Lohr KN. Clinical practice guidelines: directions for a new program. Washington (DC): National Academy Press; 1990.
2. Grimshaw J, Freemantle N, Wallace S, Russell I, Hurwitz B, Watt I, et al. Developing and implementing clinical practice guidelines. Qual Health Care 1995;4:55-64.
3. American Academy of Dermatology. Administrative regulations for clinical practice guidelines. Available from: URL:http://www.aad.org/Forms/Policies/ Uploads/AR/AR%20Evidence-Based%20Guidelines%20Clinical%20Pratice%20Guidelines. pdf. Accessed September 1, 2010.
4. Gibbons RJ, Antman EM, Smith SC. Has guideline development gone astray? No. BMJ 2010;340:c343.
5. Grol R. Has guideline development gone astray? Yes. BMJ 2010;340:c306.
6. Chang LW, Kennedy CE, Kennedy GE, Lindegren ML, Marston BJ, Kaplan JE, et al. Developing WHO guidelines with pragmatic, structured, evidence-based processes: a case study. Glob Public Health 2010;5:395-412.
7. Mechanick JI, Camacho PM, Cobin RH, Garber JR, Gharib H, Petak SM, et al. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines - 2010 update. Endocr Pract 2010;16:270-83.
8. Chung KC, Shauver MJ. Crafting practice guidelines in the world of evidence-based medicine. Plast Reconstr Surg 2009;124:1349-54.
9. Cosgrove L, Bursztajn HJ, Krimsky S, Anaya M, Walker J. Conflicts of interest and disclosure in the American Psychiatric Association's clinical practice guidelines. Psychother Psychosom 2009;78:228-32.
10. Baumann MH, Lewis SZ, Gutterman D. ACCP evidence-based guideline development: a successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations. Chest 2007;132:1015-24.
11. Bruyere O, Kanis JA, Ibar-Abadie ME, Alsayad N, Brandi ML, Burlet N, et al. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES). Osteoporos Int 2010;21:713-22.
12. Camilleri M, Parke DW. Perspective: conflict of interest and professional organizations: considerations and recommendations. Acad Med 2010;85:85-91.
13. Pavlidis N. Evidence-based medicine: development and implementation of guidelines in oncology. Eur J Cancer 2009;45(Suppl):468-70.
14. Cabral KP. How to meet national quality initiatives: best practices. J Thromb Thrombolysis 2010;29:155-8.
15. Johnson L, Stricker RB. Attorney General forces Infectious Diseases Society of America to redo Lyme guidelines due to flawed development process. J Med Ethics 2009;35:283-8.
16. Kurtin P, Stucky E. Standardize to excellence: improving the quality and safety of care with clinical pathways. Pediatr Clin North Am 2009;56:893-904.
17. Sniderman AD, Furberg CD. Why guideline-making requires reform. JAMA 2009;301:429-31.
18. Evensen AE, Sanson-Fisher R, D'Este C, Fitzgerald M. Trends in publications regarding evidence-practice gaps: a literature review. Implement Sci 2010;5:11.
19. American Academy of Dermatology. Submit an evidence-based guideline topic. Available from: URL:http://www.aad.org/research/guidelines/methodology. html. Accessed September 1, 2010.
20. National Guidelines Clearinghouse. National Guidelines Clearinghouse inclusion criteria. Available from: URL:http://www.ngc.gov/submit/inclusion. aspx. Accessed September 1, 2010.
21. American Medical Association Office of Quality Assurance. Attributes to guide the development and evaluation of practice parameters. Chicago (IL): American Medical Association; 1990.
22. Burgers JS, Cluzeau FA, Hanna SE, Hunt C, Grol R. Characteristics of high-quality guidelines: evaluation of 86 clinical guidelines developed in ten European countries and Canada. Int J Technol Assess Health Care 2003;19:148-57. (Pubitemid 36356335)
23. The AGREE Collaboration. AGREE instrument. Available from: URL:http://www.agreecollaboration.org/. Accessed September 1, 2010.
24. Evans WK, Graham ID, Cameron D, Mackay JA, Brouwers M. Practitioner feedback on lung cancer practice guidelines in Ontario. J Thorac Oncol 2006;1:10-8. (Pubitemid 47164016)
25. Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 1999;281:1900-5. (Pubitemid 29242803)
26. Stevens PE, Tomson CR. Guidelines in the United Kingdom and how they are used. Clin J Am Soc Nephrol 2009;4(Suppl):S23-9.
27. Allerberger F, Gareis R, Jindrak V, Struelens MJ. Antibiotic stewardship implementation in the EU: the way forward. Expert Rev Anti Infect Ther 2009;7:1175-83.
28. Gandara E, Moniz TT, Dolan ML, Melia C, Dudley J, Smith A, et al. Improving adherence to treatment guidelines: a blueprint. Crit Pathw Cardiol 2009;8:139-45.
29. Kiser JJ. Practice guidelines: development, application to clinical care, and role in provider education. Clin Pharmacol Ther 2009;86:239-41.
30. Cohen SM, Kataoka-Yahiro M. Provider adherence to clinical guidelines related to lipid-lowering medications. Mil Med 2010;175:122-6.
31. McCraw WM, Kelley PW, Righero AM, Latimer R. Improving compliance with diabetes clinical practice guidelines in military medical treatment facilities. Nurs Res 2010;59:S66-74.
32. Gurses AP, Murphy DJ, Martinez EA, Berenholtz SM, Pronovost PJ. A practical tool to identify and eliminate barriers to compliance with evidence-based guidelines. Jt Comm J Qual Patient Saf 2009;35:526-32.
33. Forsner T, Hansson J, Brommels M, Wistedt AA, Forsell Y. Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers. BMC Psychiatry 2010;10:8.
34. McKay MP, Vaca FE, Field C, Rhodes K. Public health in the emergency department: overcoming barriers to implementation and dissemination. Acad Emerg Med 2009;16:1132-7.
35. Olomu AB, Grzybowski M, Ramanath VS, Rogers AM, Vautaw BM, Chen B, et al. Evidence of disparity in the application of quality improvement efforts for the treatment of acute myocardial infarction: the American College of Cardiology's guidelines applied in practice initiative in Michigan. Am Heart J 2010;159:377-84.
36. Smolders M, Laurant M, Verhaak P, Prins M, van Marwijk H, Penninx B, et al. Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders? Med Care 2010;48:240-8.
37. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet 2003;362:1225-30. (Pubitemid 37255352)
38. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65. (Pubitemid 29493800)
39. Lo B, Field MJ. Conflict of interest in medical research, education, and practice. Washington (DC): National Academies Press; 2009.
40. Council of Medical Specialty Societies. Code for interactions with companies. Available from: UTL:http://www.cmss.org/codeforinteractions.aspx. Accessed September 1, 2010.
41. American Academy of Dermatology. Position statement on contemporary issues: conflict of interest. Available from: URL:http://www.aad.org/Forms/ Policies/Uploads/PS/PS-Conflict%20of%20Interest.pdf. Accessed September 1, 2010.
42. Nedza SM. A call to leadership: the role of the academic medical center in driving sustainable health system improvement through performance measurement [comment]. Acad Med 2009;84:1645-7.
43. Hsu C, Cheng SH. Practice guideline adherence and health care outcomes - use of prophylactic antibiotics during surgery in Taiwan. J Eval Clin Pract 2009;15:1091-6.
44. Nichols GA, Wang F, Pedula KL. Comparison of evidence-based versus non-evidence-based pharmacotherapy on the risk of cardiovascular hospitalization and all-cause mortality among patients with established cardiovascular disease. Am J Cardiol 2010;105:786-91.
45. Straus SE, Tetroe J, Graham ID, Zwarenstein M, Bhattacharya O, Shepperd S. Monitoring use of knowledge and evaluating outcomes. CMAJ 2010;182:E94-8.
46. Pincus HA. From PORT to policy to patient outcomes: crossing the quality chasm. Schizophr Bull 2010;36:109-11.